Divi's Laboratories

DIVISLAB · NSE · INR

9 249,00 ₹Variation par rapport à la clôture précédente: −0,46 %Variation absolue: −42,50 ₹

Clôture · 1 octobre 2026

Profil de la société

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - Specialty & Generic
Pays
Inde
Siège
Divi Towers, 500032, Hyderabad
Salariés
11 565
Cotation
DIVISLAB · NSE
Devise
INR
ISIN
INE361B01024